Esomeprazole and omeprazole may increase the serum concentrations of benzodiazepines (by using CYP2C19 inhibition) resulting in increased adverse effects for instance drowsiness, although the clinical relevance is very low in most sufferers – observe the affected person for adverse effects (e. If affected individual cannot resume their usual oral medication https://medeusresearchchem.com/product-category/research-chemicals/